18 results on '"Benson, Jr., Don M."'
Search Results
2. Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
3. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human
4. Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay
5. Rule learning in rats: serial tracking in interleaved patterns
6. Stress-induced memory enhancement for inhibitory fear conditioning in rats
7. Chapter 20 - Natural Killer Cell Immunity
8. High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma
9. A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
10. IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.
11. Phase I Trial of Lenalidomide and CCI-779 in Patients With Relapsed Multiple Myeloma: Evidence for Lenalidomide-CCI-779 Interaction via P-Glycoprotein.
12. The small molecule curcumin analog FLLL32induces apoptosis in melanoma cells via STAT3inhibition and retains the cellular response tocytokines with anti-tumor activity.
13. Can NKT cells extinguish smoldering myeloma?
14. CS1-Directed Monoclonal Antibody Therapy for Multiple Myeloma.
15. Thalidomide-Induced Fulminant Hepatic Failure.
16. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
17. MicroRNAs activate natural killer cells through Toll-like receptor signaling.
18. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.